- FDA is publicly signaling an effort to reduce barriers to generic-drug competition, potentially accelerating access to off-patent therapeutics.  
- Consumer genomics comparison: 23andMe provides both ancestry and health-trait reports, while AncestryDNA focuses on genealogy; raw genotyping files from both services are similar and can be re-analyzed with open-source tools.  
- Veritas Genetics now offers 30× whole-genome sequencing for under $1 k (down from ~$5 k three years earlier), delivering BAM and VCF files for an extra $100 fee.  
- George Church maintains a curated list of sequencing providers at http://arep.med.harvard.edu/gmc/genome_services.html, and open data can be explored on OpenSNP, OpenHumans, and the Personal Genome Project.  
- ExAC (Exome Aggregation Consortium) published a landmark 2016 Nature paper analyzing protein-coding variation in 60,706 humans, with data accessible at http://exac.broadinstitute.org.  
- Participants lament the lack of a large public genotype–phenotype cohort; an estimated $10 M could fund 10 k whole genomes if such an initiative existed.  
- Stephen Quake was appointed co-president of the new $600 M Chan Zuckerberg BioHub, whose flagship project is the Human Cell Atlas leveraging single-cell microfluidic technologies.